以統計角度探索代謝症候群判別因素之合理性

以作者查詢圖書館館藏

、以作者查詢臺灣博碩士

、以作者查詢全國書目

、勘誤回報

、線上人數：32

、訪客IP：13.58.39.23

姓名

麥茂炫(Maushan Mai) 查詢紙本館藏

畢業系所

統計研究所

論文名稱

以統計角度探索代謝症候群判別因素之合理性
(A statistical look at the appropriateness of the diagnosticcriteria of metabolism syndrome)

相關論文

★ 不需常態假設與不受離群值影響的選擇迴歸模型的方法	★ 用卜瓦松與負二項分配建構非負連續隨機變數平均數之概似函數
★ 強韌變異數分析	★ 用強韌概似函數分析具相關性之二分法資料
★ 利用Bartlett第二等式來估計有序資料的相關性	★ 相關性連續與個數資料之強韌概似分析
★ 不偏估計函數之有效性比較	★ 一個分析相關性資料的新方法-複合估計方程式
★ (一)加權概似函數之強韌性探討 (二)影響代謝症候群短期發生及消失的相關危險因子探討	★ 利用 Bartlett 第二等式來推論模型假設錯誤下的變異數函數
★ (一)零過多的個數資料之變異數函數的強韌推論 (二)影響糖尿病、高血壓短期發生的相關危險因子探討	★ 一個分析具相關性的連續與比例資料的簡單且強韌的方法
★ 時間數列模型之統計推論	★ 複合概似函數有效性之探討
★ 決定分析相關性資料時統計檢定力與樣本數的普世強韌法	★ 檢定DNA鹼基替換模型的新方法 - 考慮不同DNA鹼基間的相關性

檔案

[Endnote RIS 格式]

[Bibtex 格式]

[相關文章]

[文章引用]

[完整記錄]

[館藏目錄]

[檢視]

[下載]

本電子論文使用權限為同意立即開放。
已達開放權限電子全文僅授權使用者為學術研究之目的，進行個人非營利性質之檢索、閱讀、列印。
請遵守中華民國著作權法之相關規定，切勿任意重製、散佈、改作、轉貼、播送，以免觸法。

摘要(中)

過去研究顯示，心血管疾病與日後發生第二型糖尿病都和代謝症候群有
直接的關係。而代謝症候群判定方法為個體五個症候群因子中有三項異常
者。
本篇論文研究方向主要分三個部分。首先，我們探討個體某一個症候群
因子若愈異常，是否被判定為代謝症候群的可能性愈高。其次，我們也探
討各症候群因子彼此間的相關性，目的則是暸解五個症候群因子相關性愈
高，是否有較高的機會被判定為代謝症候群？最後，我們考慮年齡、BMI、
喝酒、抽菸、吃檳榔等危險因子，是否會影響代謝症候群的發生率。

摘要(英)

In the previous literatures, cardiovascular disease and future occurrence of
type II diabetes have direct relationship with metabolic syndrome. And the
criteria to determine the metabolic syndrome is that if there exists at least three
which are abnormal of five factors in the individual. Here are three main parts in
this thesis. First of all, we will check whether the more abnormal values of
syndrome factor becomes the higher risk of metabolic syndrome or not.
Secondly, we will talk about that the correlations between each syndrome factors,
and we will find out whether the higher correlations between the five syndrome
factors becomes the higher possibilities of metabolic syndrome? Finally, we
consider some factors such as age, BMI, drinking, smoking, and chewing betel
nut, which are risk factors, whether these risk factors affect the incidence of
metabolic syndrome or not.

關鍵字(中)

★ 代謝症候群

關鍵字(英)

★ metabolism syndrome

論文目次

摘要 .................................................................................................................... i
Abstract .............................................................................................................. ii
致謝辭 .............................................................................................................. iii
目錄 .................................................................................................................. iv
表目錄 ............................................................................................................... v
圖目錄 ............................................................................................................. vii
第一章緒論...................................................................................................... 1
第二章研究方法 .............................................................................................. 5
第三章實例分析 ............................................................................................ 16
第四章模擬研究 ............................................................................................ 33
第五章結論 ..................................................................................................... 40
參考文獻 ......................................................................................................... 42

參考文獻

[1]Reaven, G.M., (1993). Role of insulin resistance in human disease (syndrome
X) an expanded definition. Annu. Rev. Med., 44, 121-131.
[2]Alberti, K.G., Zimmet, P.Z., (1998). Definition, diagnosis and classification
of diabetes mellitus and its complications. Part 1: diagnosis and classification
of diabetes mellitus provisional report of a WHO consultation. Diabet. Med.,
15, 539–553.
[3]Balkau, B., Charles, M.A., (1999). Comment on the provisional report from
the WHO consultation: European Group for the Study of Insulin Resistnce.
Diabet. Med., 16, 442–443.
[4] National Cholesterol Education Program, (2002). Expert Panel on Detectionand
Treatment of High Blood Cholesterol in Adults. Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on D- etection,
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treat
ment Panel III) final report. Circulation, 106, 3143–3421.
[5] Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel,R.H., Franklin,
B.A., Gordon, D.J., Krauss, R.M., Savage, P.J.,Smith, SC.Jr., Spertus,
JA., Costa ,F., (2005). American Heart Association; National Heart, Lung,
and Blood Institute: Diagnosis and management of the metabolic syndrome,
an American Heart Association/National Heart, Lung and Blood Institute
scientific stat ement. Circulation, 112, 2735-2752.
[6] Zimmet ,P., Magliano, D., Matsuzawa, Y., Alberti, G., Shaw, J., (2005). The
metabolic syndrome: a global public health problem and a new definition.
J Atheroscler Thromb, 12 , 295–300.
[7]Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I.,Donato,
K.A., Fruchart, J.C., James,W.P., Loria, C.M., Smith, S.C., (2009). Harmonizing
the metabolic syndrome. A joint interim statement of the International
Diabetes Federation Task Force on Epidemiology and Prev- ention,National
Heart,Lung,and Blood Institute; American Heart Assoc- iation, World Heart
Federation; International Atherosclerosis Society,and International Association
for the Study of Obesity. Circulation,120, 1640-1645.
[8]Reaven, G.M., (1998). Banting lecture. Role of insulin resistance in humman
disease. Diabetes, 37, 1595–1607.
[9]Lillioja, S., Mott, D.M., Spraul, M., Ferraro, R., Foley, J.E., Ravussin, E.,
Knowler, W.C., Bennett, P.H., Bogardus, C., (1993).Insulin resistance and
insulin secretory dysfunction as precursors of non-insulin-dependent diabetes
mellitus.Prospective studies of Pima Indians. N. Engl. J. Med., 329(27),
44
1988-1992.
[10]Reaven, G.M., (1992).The role of insulin resistance and hyperinsulinemia
in coronary heart disease.Metabolism, 41(5 Suppl 1), 16-19
[11]Ferrannini, E., Natali, A., Capaldo, B., Lehtovirta, M., Jacob, S., Yki-Já-rvnen,
H., (1997). Insulin resistance, hyperinsulinemia, and blood pressure:
role of age and obesity. European Group for the Study of Insulin Resistance
(EGIR).Hypertension, 30, 1144–1149.
[12]Ingelsson, E., Sundstrom, J., Arnlov, J., Zethelius, B., Lind, L., (2005). Insulin
resistance and risk of congestive heart failure. J.A.M.A., 294, 334–341.
[13]Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D.S., Haffner, S.M.,
Isles, C., Macfarlane, P.W., Packard, C.J., Cobbe, S.M., Shepherd, J., 2003.
Metabolic syndrome with and without C-reactive protein as a predictor of
coronary heart disease and diabetes in the West of Scotland Coronary Prevention
Study.Circulation, 108(4), 414-419.
[14]Lakka, H.M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo,E.,
Tuomilehto, J., Salonen, J.T., 2002.The metabolic syndrome and total and
cardiovascular disease mortality in middle-aged men. J.A.M.A., 288(21),
2709-2716.
[15]Ginsberg, H.N., MacCallum, P.R., (2009).The obesity, metabolic syndrome,
and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular
disease risk and the importance of atherogenic dyslipidemia in person with
the metabolic syndrome and type 2 diabetes mellitus. Journal of the cardiometabolic
syndrome, 4(2), 113-119.
[16]Opie, L.H., (2007). Metabolic syndrome. Circulation, 115:32-35.
[17] Huang, P.L., (2009), A comprehensive definition for metabolic syndrome.
Dis. Model. Mech., 2(5-6), 231–237.
[18]Park, YW., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, MR., Heymsfield,
S.B., (2003). The metabolic syndrome: prevalence and associated risk
factor findings in the US population from the Third National Health and
Nutrition Examination Survey, 1988-1994. Arch. Inter. Med., 163(4), 427
-436.
[19]Ford, E.S.,Giles, W.H., (2003). A comparison of the prevalence of the metabolic
syndrome using two proposed definitions. Diabetes Care, 26(3), 575-
581.
[20]Ford, E.S., Giles,W.H., Dietz, W.H., (2002). Prevalence of the metabolic
syndrome among US adults: findings from the third National Health and
Nutrition Examination Survey. J.A.M.A., 287(3), 356-359.
[21] Assmann, G., Guerra, R., Fox, G., Cullen, P., Schulte, H., Willett, D.,
45
Grundy, S.M., (2007). Harmonizing the definition of the metabolic syndrome:
comparison of the criteria of the Adult Treatment Panel III and the
international Diabetes Federation in United States American and European
populations. Am. J. Cardiol., 99(4), 541-822.
[22]Balkau, B., Charles, M.A., Drivsholm,T., Borch-Johnsen, K., Wareham N,
Yudkin,J.S., Morris, R., Zavaroni, I., van Dam, R., Feskins, E., Gabriel, R.,
Diet, M., Nilsson, P., Hedblad, B., (2002). European Group For The Study of
Insulin Resistance(EGIR). Frequency of the WHO metabolic syndrome in
European cohorts, and an alternative definition of an insulin resistance
syndrome. Diabetes Metab., 28(5), 364-376.
[23] Anand, S.S., Yi, Q., Gerstein, H., Lonn, E., Jacobs, R., Vuksan, V., Teo, K.,
Davis, B., Montague, P., Yusuf, S., (2003). Study of Health Assessment and
Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in
Aboriginal Peoples Investigators.Relationship of metabolic syndrome and
fibrinolytic dysfunction to cardiovascular disease. Circulation, 108(4), 420-
425.
[24]Gupta, R., Deedwania, P.C., Gupta, A., Rastogi, S., Panwar, R.B., Kotha- ri,
K, (2004).Prevalence of metabolic syndrome in an Indian urban population.
Int. J. Cardiol., 97(2), 257-261.
[25] Kozan, O., Oguz, A., Abaci, A., Erol, C., Ongen, Z., Temizhan, A., Cel- ik,
S., (2007). Prevalence of the metabolic syndrome among Turkish adults.
Eur. J. Clin. Nutr., 61(4),548-553.
[26]Zabetian, A., Hadaegh, F., Azizi, F., (2007). Prevalence of metabolic syndrome
in Iranian adult population, concordance between the IDF with the
ATPIII and the WHO definitions. Diabetes Res Clin. Pract., 77(2), 251-257.
[27]Chuang, S.Y., Chen, C.H., Chou, P., 2004. Prevalence of metabolic Syndrome
in a large health check-up population in Taiwan. J. Chin. Med. Assoc.,
67(12), 611-620.
[28]Chen, H.J., Pan, W.H., (2007). Probable blind spot in the International
Diabetes Federation definition of metabolic syndrome. Obesity (Silver Spring),
15(5), 1096-1100.
[29]Chen, H.J., Bai, C.H., Yeh, W.T., Chiu, H.C., Pan, W.H., (2006). Influence
of metabolic syndrome and general obesity on risk of ischemic stroke,
37(4), 1060-1064.
[30]Lawrence, J., and Marion, R., (1991), A Method for Generating High-
Dimensional Multivariate Binary Variates,The American Statistician,
Vol.45, No.4, pp 302-304.

指導教授

鄒宗山(Tsung-Shan Tsou)

審核日期

2011-7-8

推文